CLINICAL_TRIALS
trial_result
· 2010-03-16
Clinical Trial Update: Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3) [Phase 4]
Summary
Phase 4 BRAVE 3 trial evaluating abciximab in patients with acute myocardial infarction undergoing primary PCI after clopidogrel pretreatment. The study status …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED